FORMAN ERIC 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Nov 21, 2022
Insider Transaction Report
Form 4
FORMAN ERIC
10% Owner
Transactions
- Purchase
Common Stock
2022-11-17$0.54/sh+4,852$2,619→ 81,935 total(indirect: By Trust) - Purchase
Common Stock
2022-11-18$0.57/sh+7,648$4,336→ 89,583 total(indirect: By Trust) - Purchase
Common Stock
2022-11-18$0.56/sh+2,500$1,400→ 92,083 total(indirect: By Trust) - Purchase
Common Stock
2022-11-18$0.56/sh+6,059$3,389→ 98,142 total(indirect: By Trust)
Holdings
- 38,598
Common Stock